1. Efficacy, safety, and health-related quality of life from a global phase 3 study of tislelizumab as second- or third-line therapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC): RATIONALE 303. (March 2022) Authors: Zhou, Caicun; Huang, Dingzhi; Yu, Xinmin; Liu, Yunpeng; Fan, Yun; Shu, Yongqian; Ma, Zhiyong; Wang, Ziping; Cheng, Ying; Wang, Jie; Hu, Sheng; Liu, Zhihua; Poddubskaya, Elena; Disel, Umut; Akopov, Audrey; Ma, Yiyuan; Wang, Yan; Li, Songzi; Yu, Cunjing; Barnes, Gisoo Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor–Amplified Gastroesophageal Cancer: Retrospective Global Experience. Issue 22 (1st August 2022) Authors: Maron, Steven B.; Moya, Stephanie; Morano, Federica; Emmett, Matthew J.; Chou, Joanne F.; Sabwa, Shalom; Walch, Henry; Peterson, Bryan; Schrock, Alexa B.; Zhang, Liangliang; Janjigian, Yelena Y.; Chalasani, Sree; Ku, Geoffrey Y.; Disel, Umut; Enzinger, Peter; Uboha, Nataliya; Kato, Shumei; Yoshin... Journal: Journal of clinical oncology Issue: Volume 40:Issue 22(2022) Page Start: 2458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Pan‐Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA. (11th October 2019) Authors: Disel, Umut; Madison, Russell; Abhishek, Kumar; Chung, Jon H.; Trabucco, Sally E.; Matos, Asli O.; Frampton, Garrett M.; Albacker, Lee A.; Reddy, Venkataprasanth; Karadurmus, Nuri; Benson, Adam; Webster, Jennifer; Paydas, Semra; Cabanillas, Ruben; Nangia, Chaitali; Ozturk, M.A.; Millis, Sherri Z.... Journal: Oncologist Issue: Volume 25:Number 1(2020) Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗